AmanSaraf

JUBILANT INGREVIA - Positional Study

Long
NSE:JUBLINGREA   JUBILANT INGREVIA LTD
About:
Jubilant Ingrevia was Demerged from Jubilant Lifesciences in February 2021. It is in the business of Speciality chemicals, Animal & human nutrition, life science chemicals, ethanol etc.

- Stock is in a continuous uptrend.
- Price today crossed the previous swing high after forming a base at Support Level (which was earlier a resistance)
- Price broke out with good volumes with good accumulation activity at the end of July.
- Spread chart also gave a breakout of the previous swing high.

Financial Results:
- Jubilant's QoQ Sales growth is 67%
- QoQ Profit growth is 211%

Jubilant Ingrevia is looking financially & technically sound. It looks good for positional investment.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.